Bringing the fundamentals into focus…
Back to Thermo Fisher Scientific Inc.
How Thermo Fisher Scientific Inc. stacks up
TMO · against 15 other Healthcare companies of similar size
Overall
47/ 100
Below the middle of the pack.
Ranked #11 of 16 · scores higher than 27% of peers
Bars: peers in each 10-point band of the overall score4 peers with an overall score of 40–49, including TMO · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around TMO| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 177.5B USD | 71 | 92 | 60 | 99 | 2 / 2 | |
| 2 | 134.5B USD | 70 | 55 | 58 | 96 | 0 / 2 | |
| 3 | 155.7B USD | 64 | 47 | 73 | 94 | 1 / 2 | |
| 4 | 285.2B USD | 63 | 66 | 64 | 86 | 1 / 2 | |
| 4 | 162.93T ARS (≈$162.9B) | 63 | 82 | 72 | 78 | 2 / 2 | |
| 7 | 317.9B CHF (≈$365.6B) | 60 | 70 | 49 | 97 | 2 / 2 | |
| 8 | 249.4B USD | 55 | 60 | 63 | 90 | 2 / 2 | |
| 9 | 505.4B USD | 53 | 48 | 66 | 87 | 2 / 2 | |
| 10 | 161.8B USD | 50 | 53 | 47 | 68 | 2 / 2 | |
| 11 | 258.2B USD | 47 | 53 | 44 | 71 | 2 / 2 | |
| 11 | 363.0B USD | 47 | 65 | 38 | 61 | 2 / 2 | |
| 13 | 189.3B USD | 45 | 57 | 26 | 68 | 2 / 2 | |
| 13 | 171.0B USD | 45 | 66 | 14 | 68 | 2 / 2 | |
| 15 | 356.9B USD | 37 | 54 | 20 | 55 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score